Document is current
Any future updates will be listed below
-
Authors
DiGiacomo, Daniel V. https://orcid.org/0000-0001-6344-7246
Roelstraete, Bjorn
Hammarström, Lennart
Farmer, Jocelyn R.
Khalili, Hamed
Ludvigsson, Jonas F.
-
Funding
Funding for this research was provided by:
Massachusetts General Hospital
Crohn's and Colitis Foundation of America
Karolinska Institutet
Stockholm County Council
Karolinska Institute
- License Information
-
More Information
Article History
Received: 14 January 2023
Accepted: 21 April 2023
First Online: 10 May 2023
Declarations
:
: This study was approved by the Stockholm Ethics Review Board (2014/1287–31/4).
: Given the register-based nature of this study, participant informed consent has been waived.
: Not applicable.
: DD receives grant support from Pfizer. HK receives consulting fees from Takeda. HK also receives grant support from Takeda and Pfizer. JFL has coordinated an unrelated study on behalf of the Swedish IBD quality register (SWIBREG). That study received funding from Janssen corporation. JFL has also received financial support from MSD developing a paper reviewing national healthcare registers in China.
